SIGA TECHNOLOGIES INC 4
4 · SIGA TECHNOLOGIES INC · Filed Oct 2, 2009
Insider Transaction Report
Form 4
MJALLI ADNAN M M
Director
Transactions
- Tax Payment
Common Stock
2009-09-30$7.80/sh−444,665$3,468,387→ 3,851,969 total(indirect: by TransTech Pharma, Inc.) - Sale
Common Stock
2009-09-30$6.24/sh−3,851,969$24,036,287→ 0 total(indirect: by TransTech Pharma, Inc.) - Exercise of In-Money
Warrant (right to buy)
2009-09-30−1,824,412→ 0 total(indirect: By TransTech Pharma, Inc.)Exercise: $1.90From: 2004-01-08Exp: 2011-01-08→ Common Stock (1,824,412 underlying) - Exercise of In-Money
Common Stock, par value $0.0001 per share ("Common Stock")
2009-09-30$1.90/sh+1,824,412$3,466,383→ 4,296,634 total(indirect: by TransTech Pharma, Inc.)
Footnotes (2)
- [F1]On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
- [F2]The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.